Intellectual Property India Publishes Patent Application for 'Methods And Compositions For Treating Hsd-1-Mediated Disorders' Filed by Sparrow Pharmaceuticals, Inc.

MUMBAI, India, Aug. 22 -- Intellectual Property India has published a patent application (202517069641 A) filed by Sparrow Pharmaceuticals, Inc., Portland, U.S.A., on July 22, for 'methods and compositions for treating hsd-1-mediated disorders.'

Inventor(s) include Evarts, Jr. Jerry B.

The application for the patent was published on Aug. 22, under issue no. 34/2025.

According to the abstract released by the Intellectual Property India: "Provided are processes for preparing triazole derivatives and compositions for use as HSD-1 inhibitors."

The patent application was internationally filed on Jan. 05, 2024, under International application No.PCT/US2024/010474.

Disclaimer: Curated by HT Syndication.